U.S. flag

An official website of the United States government

NM_198291.3(SRC):c.1579G>A (p.Glu527Lys) AND multiple conditions

Germline classification:
Likely pathogenic (1 submission)
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001003535.1

Allele description [Variation Report for NM_198291.3(SRC):c.1579G>A (p.Glu527Lys)]

NM_198291.3(SRC):c.1579G>A (p.Glu527Lys)

Gene:
SRC:SRC proto-oncogene, non-receptor tyrosine kinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
20q11.23
Genomic location:
Preferred name:
NM_198291.3(SRC):c.1579G>A (p.Glu527Lys)
HGVS:
  • NC_000020.11:g.37403347G>A
  • NG_023033.1:g.63663G>A
  • NM_005417.5:c.1579G>A
  • NM_198291.3:c.1579G>AMANE SELECT
  • NP_005408.1:p.Glu527Lys
  • NP_005408.1:p.Glu527Lys
  • NP_938033.1:p.Glu527Lys
  • LRG_1018:g.63663G>A
  • NC_000020.10:g.36031750G>A
  • NM_005417.4:c.1579G>A
  • P12931:p.Glu527Lys
Protein change:
E527K; GLU527LYS
Links:
UniProtKB: P12931#VAR_076919; OMIM: 190090.0002; dbSNP: rs879255268
NCBI 1000 Genomes Browser:
rs879255268
Molecular consequence:
  • NM_005417.5:c.1579G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_198291.3:c.1579G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Primary myelofibrosis
Synonyms:
Myelofibrosis, somatic; Suspected idiopathic myelofibrosis
Identifiers:
MONDO: MONDO:0009692; MeSH: D055728; MedGen: C0001815; Orphanet: 824; OMIM: 254450
Name:
Osteoporosis
Identifiers:
MONDO: MONDO:0005298; MedGen: C0029456; OMIM: 166710; Human Phenotype Ontology: HP:0000939
Name:
Thrombocytopenia
Identifiers:
MONDO: MONDO:0002049; MeSH: D013921; MedGen: C0040034; Human Phenotype Ontology: HP:0001873

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV001161862NIHR Bioresource Rare Diseases, University of Cambridge
no assertion criteria provided
Likely pathogenicunknownresearch

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownyes1not providednot provided1not providedresearch

Citations

PubMed

Whole-genome sequencing of patients with rare diseases in a national health system.

Turro E, Astle WJ, Megy K, Gräf S, Greene D, Shamardina O, Allen HL, Sanchis-Juan A, Frontini M, Thys C, Stephens J, Mapeta R, Burren OS, Downes K, Haimel M, Tuna S, Deevi SVV, Aitman TJ, Bennett DL, Calleja P, Carss K, Caulfield MJ, et al.

Nature. 2020 Jul;583(7814):96-102. doi: 10.1038/s41586-020-2434-2. Epub 2020 Jun 24.

PubMed [citation]
PMID:
32581362
PMCID:
PMC7610553

Details of each submission

From NIHR Bioresource Rare Diseases, University of Cambridge, SCV001161862.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedresearch PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyes1not providednot provided1not providednot providednot provided

Last Updated: May 7, 2024